Latest News

ESC Congress 2024 Reveals its Late-Breaking Scientific Sessions
Written by: ESC Congress, Radcliffe Cardiology
ESC Congress 2024 Reveals its Late-Breaking Scientific Sessions
ESC Congress 2024 Unveils its Hot Line Trials
Written by: Radcliffe Cardiology, ESC Congress
ESC Congress 2024 Unveils its Hot Line Trials
Novel Agent Data for Obesity Released at ADA 2024 Scientific Sessions Show Benefits for Glycaemic and Blood Pressure Control
Written by: Radcliffe Cardiology, Greg Guillory, Karen Bell
Novel Agent Data for Obesity Released at ADA 2024 Scientific Sessions Show Benefits for Glycaemic and Blood…
FLOW Trial Analysis: Deep Dive into the SGLT2-GLP-1 Combination Therapy
Written by: Radcliffe Cardiology, Greg Guillory, Karen Bell
FLOW Trial Analysis: Deep Dive into the SGLT2-GLP-1 Combination Therapy
SURMOUNT-OSA: Tirzepatide Significantly Improves Sleep Apnea and Cardiometabolic Risk Factors
Written by: Radcliffe Cardiology, Greg Guillory, Karen Bell
SURMOUNT-OSA: Tirzepatide Significantly Improves Sleep Apnea and Cardiometabolic Risk Factors
Timing of Cardio-Kidney Protection with SGLT2 Inhibitors
Written by: Radcliffe Cardiology, Karen Bell; Special Editor: Greg Guillory
Timing of Cardio-Kidney Protection with SGLT2 Inhibitors
Semaglutide May Protect Kidney Function in Individuals with Overweight or Obesity and Cardiovascular Disease
Written by: European Renal Association
Semaglutide May Protect Kidney Function in Individuals with Overweight or Obesity and Cardiovascular Disease
Featured Clinical Research to be Presented at SCAI 2024
Written by: SCAI 2024, Radcliffe Cardiology
Featured Clinical Research to be Presented at SCAI 2024
Heart Rhythm 2024 Unveils its Late Breaking Trial Program
Written by: HRS Conference, Radcliffe Cardiology
Heart Rhythm 2024 Unveils its Late Breaking Trial Program
EuroPCR Congress 2024 Reveals its Late-Breaking Clinical Trial Presentations
Written by: EuroPCR 2024, Radcliffe Cardiology
EuroPCR Congress 2024 Reveals its Late-Breaking Clinical Trial Presentations

External news

Written by: Cardiovascular Business
FDA clears AI screening tool for cardiac amyloidosis
Written by: Cardiovascular Business
IVUS-guided PCI reduces risks in patients with diabetes
Written by: Cardiovascular Business
Martha Gulati highlights 'exciting' progress in preventive cardiology
Written by: Cardiovascular Business
Medtronic using AI to identify more TAVR patients in need
Written by: Medscape
For AF, LAA Rivals Anticoagulants After Ablation
Written by: Medscape
How Impactful is EMPACT-MI on Heart Failure: EMPACT-MI Trial
Written by: Cardiac Vascular News
Medtronic begins multicenter study to address health disparities in structural heart disease care
Written by: Cardiac Vascular News
Akumin AXIS™ To Be Unveiled at RSNA 2024: Transforming Patient Access in Radiology
Written by: Medscape
Recognizing Burnout: Why Physicians Often Miss the Signs in Themselves
Written by: Medscape
Breaking the Cycle: Self-Compassion Matters for Physicians